INOVIQ Ltd (ASX:IIQ) is a biotechnology company developing next-generation diagnostics and therapeutics for cancer.  INOVIQ has commercialised its fast, efficient and scalable EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer.  The company is advancing clinical-stage diagnostics for detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumours.

Biotechnology

Health Diagnostics

Life Sciences

Therapeutics

INOVIQ Ltd (ASX:IIQ)

INOVIQ Ltd (ASX:IIQ)'s headquarters in Notting Hill, Australia

INOVIQ Ltd (ASX:IIQ)

Org chart

Teams

Offices

Similar companies